US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
SE

SERA

Stock SERA PROGNOSTICS, INC.
$2.07

Nasdaq Global Market · Healthcare · US

Open in terminal Compare
Alert
Sharia status
NOT COMPLIANT
Per our secondary compliance provider · assessed 2026-08-25
Purification 100.00%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure2 of 4 timeframes bullish · 82.4% aligned
VWAPPrice holding above VWAP ($2.01)
VolumeRelative volume 3.7× the 20-day average
Momentum10-day rate of change +3.0%

Sera Prognostics Inc - Ordinary Shares Class A (SERA) is currently considered not halal (non-compliant), per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

Market & analysts
Price target
$5.50
+165.7% · 2 analysts
Institutional own.
50.2%
of shares
Momentum (10d)
+3.0%
rate of change
SMC grade
D · 48
82.4% aligned
NON-COMPLIANT
Sharia compliance
100.00%
Purification ratio
D · 48
SMC grade — 82.4% timeframe alignment
+3.0%
Rate of change (10d)
$5.50
Price target (+165.7%) · 2 analysts
50.2%
Institutional ownership

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for SERA — this runs off the critical path so the page paints first. It will appear here on its own.

3.753.212.672.131.592025-09-182026-03-192026-09-17

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
1.96
S2
1.98
S1
2.00
PIVOT
2.02
R1
2.04
R2
2.06
R3
2.08

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
1.73 2.31
±14.58% from 2.02, made 2026-09-05 · resolves 2026-09-12
STRONG SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 49745 forecast(s) are currently open and will be scored automatically when their horizon expires.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG BUY
19 indicators
OscillatorsSTRONG BUY
2 buy · 4 neutral · 1 sell
Moving averagesSTRONG BUY
9 buy · 0 neutral · 3 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)53.30NEUTRAL
Stochastic %K (14)50.00NEUTRAL
CCI (20)0.58NEUTRAL
Williams %R (14)-50.00NEUTRAL
MACD (12,26,9)-0.00SELL
ROC (10)2.98BUY
Momentum (10)0.06BUY
EMA (10)2.03BUY
SMA (10)2.02BUY
EMA (20)2.03BUY
SMA (20)2.06BUY
EMA (30)2.04BUY
SMA (30)2.04BUY
EMA (50)2.03BUY
SMA (50)2.05BUY
EMA (100)2.08SELL
SMA (100)1.99BUY
EMA (200)2.39SELL
SMA (200)2.33SELL

About Sera Prognostics Inc - Ordinary Shares Class A

Healthcare · Medical Devices

Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

sera.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 43
🕐 1H BEARISH 28
⏱ 15-Min BULLISH 114
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-0.01
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-09-08 · Asset managers net 912361 (-21819)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.